semaglutide diabetes trial What the SELECT of means for clinicians Novo Nordisk's semaglutide shows promise

10.1097/00003246-198902000-00002 15 DepauwP

Our Staff will work closely with you to determine if semaglutide is a suitable option for your weight loss journey

The search included all spontaneous reports of psychiatric adverse drug reactions, regardless of the dose, frequency, or route of administration of the selected medication

If glycemic control deteriorates after starting olanzapine, that's not just "the diabetes progressing" it may be causal, and deserves a medication reconciliation flag, not just an insulin dose adjustment

Currently, an obesity epidemic is observed in many countries and further research on the use of semaglutide in the treatment of obesity is indicated